Radioembolization for colorectal cancer liver metastases: current role and future opportunities – the medical oncologist’s perspective
Peter Gibbs, Jeanne Tie, Lourens Bester
Colorectal Cancer | Future Medicine Ltd | Published : 2014
SUMMARY The liver is the most common and often the only site of metastatic disease in patients with metastatic colorectal cancer. For patients who do not have resectable disease, a number of liver-directed therapies are increasingly being used in routine clinical practice, including yttrium-90 radioembolization. The challenge for the medical oncologist is how best to integrate this promising new option into routine practice in the setting of ever-evolving standard systemic therapy options. Here we review the most recent data on the efficacy and safety of yttrium-90, considerations when selecting patients for treatment and we examine the potential impact of current clinical trials.